Items Tagged ‘Richard Weinshilboum’

August 20, 2015

Pharmacogenomics: The Future of Prescribing Could Reside in Your DNA

By Jeff Briggs Jeff Briggs

In the era of modern medicine, the standard of health care is constantly improving. But what happens when a patient does not respond to standard treatment? Why does chemotherapy work effectively against cancer in some patients, but not in others? Why do some patients experience adverse reactions to medication? The key to unlocking these mysteries […]

View full entry

Tags: center for individualized medicine, Dr. Richard Weinshilboum, genomic medicine, individualized medicine, Individualized Medicine Conference 2015, M.D., pharmacogenomics, Precision Medicine, Richard Weinshilboum


Individualizing Medicine 2014: Day Two Recap

October 7, 2014

Individualizing Medicine 2014: Day Two Recap

By Sam Smith Sam Smith

Day two of the Individualizing Medicine 2014 Conference dispelled any notion of a conference on genomics being a gathering of humorless, stuffy scientists talking about the minutiae of genetic alphabet soup. Bob Dylan and Fifty Shades of Grey, Clint Eastwood and Dr. Seuss were intermixed in with informative talks that centered on the power of […]

View full entry

Tags: 23andMe, beauty project, ceci connolly, center for individualized medicine, Conference, dan roden, genomics, Gianrico Farrugia, im2014, individualized medicine, Individualized Medicine Conference, individualizing medicine 2014


March 13, 2014

Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations: Genome-Wide Associations

By Mystery User

A recently published article in the area of Pharmacogenomics set out to identify genetic factors in Citalopram (CT) and escitalopram (S-CT), which are among the most widely prescribed serotonin reuptake inhibitors (SSRIs) used to treat Major Depressive Disorder (MDD), that contribute to variation in plasma concentrations of CT or S-CT and their metabolites in MDD patients treated […]

View full entry

Tags: citalopram, dna test, DNA Testing, escitalopram, gene sequencing, genome science, genome-wide association studies, genomic medicine, genomics, individualized medicine, major depressive disorder, personal genomics


Contact Us · Privacy Policy